BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33000154)

  • 21. Reversible brain atrophy in glutaric aciduria type 1.
    Numata-Uematsu Y; Sakamoto O; Kakisaka Y; Okubo Y; Oikawa Y; Arai-Ichinoi N; Kure S; Uematsu M
    Brain Dev; 2017 Jun; 39(6):532-535. PubMed ID: 28143689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triple therapy with pyridoxine, arginine supplementation and dietary lysine restriction in pyridoxine-dependent epilepsy: Neurodevelopmental outcome.
    Coughlin CR; van Karnebeek CD; Al-Hertani W; Shuen AY; Jaggumantri S; Jack RM; Gaughan S; Burns C; Mirsky DM; Gallagher RC; Van Hove JL
    Mol Genet Metab; 2015; 116(1-2):35-43. PubMed ID: 26026794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subependymal mass lesions and peripheral polyneuropathy in adult-onset glutaric aciduria type I.
    Herskovitz M; Goldsher D; Sela BA; Mandel H
    Neurology; 2013 Aug; 81(9):849-50. PubMed ID: 23884036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanistic effects of amino acids and glucose in a novel glutaric aciduria type 1 cell model.
    Fu X; Gao H; Tian F; Gao J; Lou L; Liang Y; Ning Q; Luo X
    PLoS One; 2014; 9(10):e110181. PubMed ID: 25333616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency).
    Mills PB; Footitt EJ; Mills KA; Tuschl K; Aylett S; Varadkar S; Hemingway C; Marlow N; Rennie J; Baxter P; Dulac O; Nabbout R; Craigen WJ; Schmitt B; Feillet F; Christensen E; De Lonlay P; Pike MG; Hughes MI; Struys EA; Jakobs C; Zuberi SM; Clayton PT
    Brain; 2010 Jul; 133(Pt 7):2148-59. PubMed ID: 20554659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial outcome of early dietary lysine restriction as an adjunct to pyridoxine therapy in a child with pyridoxine dependant epilepsy due to Antiquitin deficiency.
    Kava MP; Bryant L; Rowe P; Lewis B; Greed L; Balasubramaniam S
    JIMD Rep; 2020 Jul; 54(1):9-15. PubMed ID: 32685344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective effects of L-carnitine on behavioral alterations and neuroinflammation in striatum of glutaryl-COA dehydrogenase deficient mice.
    Guerreiro G; Faverzani J; Moura AP; Volfart V; Gome Dos Reis B; Sitta A; Gonzalez EA; de Lima Rosa G; Coitinho AS; Baldo G; Wajner M; Vargas CR
    Arch Biochem Biophys; 2021 Sep; 709():108970. PubMed ID: 34181873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and management of glutaric aciduria type I--revised recommendations.
    Kölker S; Christensen E; Leonard JV; Greenberg CR; Boneh A; Burlina AB; Burlina AP; Dixon M; Duran M; García Cazorla A; Goodman SI; Koeller DM; Kyllerman M; Mühlhausen C; Müller E; Okun JG; Wilcken B; Hoffmann GF; Burgard P
    J Inherit Metab Dis; 2011 Jun; 34(3):677-94. PubMed ID: 21431622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult-onset glutaric aciduria type I: rare presentation of a treatable disorder.
    Gelener P; Severino M; Diker S; Teralı K; Tuncel G; Tuzlalı H; Manara E; Paolacci S; Bertelli M; Ergoren MC
    Neurogenetics; 2020 Jul; 21(3):179-186. PubMed ID: 32306145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complementary dietary treatment using lysine-free, arginine-fortified amino acid supplements in glutaric aciduria type I - A decade of experience.
    Kölker S; Boy SP; Heringer J; Müller E; Maier EM; Ensenauer R; Mühlhausen C; Schlune A; Greenberg CR; Koeller DM; Hoffmann GF; Haege G; Burgard P
    Mol Genet Metab; 2012 Sep; 107(1-2):72-80. PubMed ID: 22520952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene.
    Plecko B; Paul K; Paschke E; Stoeckler-Ipsiroglu S; Struys E; Jakobs C; Hartmann H; Luecke T; di Capua M; Korenke C; Hikel C; Reutershahn E; Freilinger M; Baumeister F; Bosch F; Erwa W
    Hum Mutat; 2007 Jan; 28(1):19-26. PubMed ID: 17068770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of dietary lysine restriction and arginine supplementation in two patients with pyridoxine-dependent epilepsy.
    Yuzyuk T; Thomas A; Viau K; Liu A; De Biase I; Botto LD; Pasquali M; Longo N
    Mol Genet Metab; 2016 Jul; 118(3):167-172. PubMed ID: 27324284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomics analysis of antiquitin deficiency in cultured human cells and plasma: Relevance to pyridoxine-dependent epilepsy.
    Crowther LM; Poms M; Zandl-Lang M; Abela L; Hartmann H; Seiler M; Mathis D; Plecko B
    J Inherit Metab Dis; 2023 Jan; 46(1):129-142. PubMed ID: 36225138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lysine degradation pathway: Subcellular compartmentalization and enzyme deficiencies.
    Leandro J; Houten SM
    Mol Genet Metab; 2020; 131(1-2):14-22. PubMed ID: 32768327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Progress of glutaric aciduria type I].
    Gao JZ; Luo XP
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):912-4. PubMed ID: 23324148
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of age at onset and newborn screening on outcome in organic acidurias.
    Heringer J; Valayannopoulos V; Lund AM; Wijburg FA; Freisinger P; Barić I; Baumgartner MR; Burgard P; Burlina AB; Chapman KA; I Saladelafont EC; Karall D; Mühlhausen C; Riches V; Schiff M; Sykut-Cegielska J; Walter JH; Zeman J; Chabrol B; Kölker S;
    J Inherit Metab Dis; 2016 May; 39(3):341-353. PubMed ID: 26689403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency.
    Hoffmann GF; Athanassopoulos S; Burlina AB; Duran M; de Klerk JB; Lehnert W; Leonard JV; Monavari AA; Müller E; Muntau AC; Naughten ER; Plecko-Starting B; Superti-Furga A; Zschocke J; Christensen E
    Neuropediatrics; 1996 Jun; 27(3):115-23. PubMed ID: 8837070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and molecular investigation in Chinese patients with glutaric aciduria type I.
    Zhang Y; Li H; Ma R; Mei L; Wei X; Liang D; Wu L
    Clin Chim Acta; 2016 Jan; 453():75-9. PubMed ID: 26656312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery.
    Gonzalez Melo M; Remacle N; Cudré-Cung HP; Roux C; Poms M; Cudalbu C; Barroso M; Gersting SW; Feichtinger RG; Mayr JA; Costanzo M; Caterino M; Ruoppolo M; Rüfenacht V; Häberle J; Braissant O; Ballhausen D
    Mol Genet Metab; 2021 Jun; 133(2):157-181. PubMed ID: 33965309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute renal proximal tubule alterations during induced metabolic crises in a mouse model of glutaric aciduria type 1.
    Thies B; Meyer-Schwesinger C; Lamp J; Schweizer M; Koeller DM; Ullrich K; Braulke T; Mühlhausen C
    Biochim Biophys Acta; 2013 Oct; 1832(10):1463-72. PubMed ID: 23623985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.